Published: 08/03/2022 12:13 GMT MediWound Ltd (MDWD) - Mediwound Announces U.S. FDA Acceptance of Biologics License Application for Nexobrid for the Treatment of Severe Thermal Burns.
Mediwound Ltd - FDA Assigned a Prescription Drug User Fee Act (pdufa) Target Date of January 1, 2023.
